Two major clinical trials evaluating the potential of the weight-loss drug semaglutide to treat Alzheimer’s disease have ...

An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a ...

We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

Novo Nordisk said on Monday an older oral version of its semaglutide drug failed to meet its main ​goal in late-stage trials ...

Scientists have uncovered a surprising mechanism by which a brain enzyme called OTULIN controls the expression of tau, the ...

Shares of Biogen rose 3% following news of Novo's Alzheimer's trial failure. Biogen and partner Eisai's Leqembi and rival Eli ...

Almost all community-dwelling older adults with advanced dementia in Singapore had at least one potentially burdensome intervention in their last year of life, according to a November article ...

Scientists hail ‘very exciting’ findings that explain why Alzheimer’s patients forget their loved ones, and say drugs are ...

One of the most devastating moments for family members of a patient with Alzheimer’s is when their loved one forgets who they ...